HZB-0071 by Heilongjiang ZBD Pharmaceutical for Adenocarcinoma: Likelihood of Approval

HZB-0071 is under clinical development by Heilongjiang ZBD Pharmaceutical and currently in Phase I for Adenocarcinoma.

Source link
#HZB0071 #Heilongjiang #ZBD #Pharmaceutical #Adenocarcinoma #Likelihood #Approval